MiR-451 is decreased in hypertrophic cardiomyopathy and regulates autophagy by targeting TSC1

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 11, 2014, Pages 2266-2274

  Song, Lei ^a   Su, Ming ^a   Wang, Shuiyun ^a   Zou, Yubao ^a   Wang, Xiaojian ^a   Wang, Yilu ^b   Cui, Hongli ^c   Zhao, Peng ^c   Hui, Rutai ^a   Wang, Jizheng ^a  

^a FUWAI HOSPITAL   (China)

^b CHINA MEITAN GENERAL HOSPITAL   (China)

^c QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Autophagy; Hypertrophic cardiomyopathy; MicroRNA 451; MicroRNAs microarray; Tuberous sclerosis complex 1

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; BECN1 PROTEIN, HUMAN; MEMBRANE PROTEIN; MICRORNA; MIRN451 MICRORNA, HUMAN; TUBEROUS SCLEROSIS COMPLEX 1 PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL; AUTOPHAGY; BIOSYNTHESIS; CARDIAC MUSCLE CELL; CARDIOMEGALY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; PATHOLOGY; RAT;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CARDIOMEGALY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MEMBRANE PROTEINS; MICRORNAS; MYOCYTES, CARDIAC; RATS; TUMOR SUPPRESSOR PROTEINS;

EID: 84911435656     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12380     Document Type: Article

References (39)

1. Ommen SR. Hypertrophic cardiomyopathy. Curr Probl Cardiol. 2011; 36: 409-53.
2. Marston S, Copeland O, Gehmlich K, et al. How do MYBPC3 mutations cause hypertrophic cardiomyopathy? J Muscle Res Cell Motil. 2012; 33: 75-80.
3. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002; 287: 1308-20.
4. Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet. 2013; 381: 242-55.
5. Schlossarek S, Englmann DR, Sultan KR, et al. Defective proteolytic systems in Mybpc3-targeted mice with cardiac hypertrophy. Basic Res Cardiol. 2012; 107: 235.
6. Cilvik SN, Wang JI, Lavine KJ, et al. Fibroblast growth factor receptor 1 signaling in adult cardiomyocytes increases contractility and results in a hypertrophic cardiomyopathy. PLoS ONE. 2013; 8: e82979.
7. Schramm C, Fine DM, Edwards MA, et al. The PTPN11 loss-of-function mutation Q510E-Shp2 causes hypertrophic cardiomyopathy by dysregulating mTOR signaling. Am J Physiol Heart Circ Physiol. 2012; 302: H231-43.
8. Liu X, Ye B, Miller S, et al. Ablation of ALCAT1 mitigates hypertrophic cardiomyopathy through effects on oxidative stress and mitophagy. Mol Cell Biol. 2012; 32: 4493-504.
9. Patel R, Nagueh SF, Tsybouleva N, et al. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation. 2001; 104: 317-24.
10. Watkins H, Conner D, Thierfelder L, et al. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet. 1995; 11: 434-7.
11. Niimura H, Bachinski LL, Sangwatanaroj S, et al. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med. 1998; 338: 1248-57.
12. Ucar A, Gupta SK, Fiedler J, et al. The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat Commun. 2012; 3: 1078.
13. Callis TE, Pandya K, Seok HY, et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest. 2009; 119: 2772-86.
14. Care A, Catalucci D, Felicetti F, et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med. 2007; 13: 613-8.
15. Wang J, Huang W, Xu R, et al. MicroRNA-24 regulates cardiac fibrosis after myocardial infarction. J Cell Mol Med. 2012; 16: 2150-60.
16. Rao PK, Toyama Y, Chiang HR, et al. Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circ Res. 2009; 105: 585-94.
17. Ge Y, Pan S, Guan D, et al. MicroRNA-350 induces pathological heart hypertrophy by repressing both p38 and JNK pathways. Biochim Biophys Acta. 2013; 1832: 1-10.
18. Wang C, Wang S, Zhao P, et al. MiR-221 promotes cardiac hypertrophy in vitro through the modulation of p27 expression. J Cell Biochem. 2012; 113: 2040-6.
19. Wang X, Zhu H, Zhang X, et al. Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1. Cardiovasc Res. 2012; 94: 379-90.
20. Zhang X, Wang X, Zhu H, et al. Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death. J Mol Cell Cardiol. 2010; 49: 841-50.
21. Schwartz RA, Fernandez G, Kotulska K, et al. Tuberous sclerosis complex: advances in diagnosis, genetics, and management. J Am Acad Dermatol. 2007; 57: 189-202.
22. Bhaskar PT, Hay N. The two TORCs and Akt. Dev Cell. 2007; 12: 487-502.
23. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008; 132: 27-42.
24. Taneike M, Yamaguchi O, Nakai A, et al. Inhibition of autophagy in the heart induces age-related cardiomyopathy. Autophagy. 2010; 6: 600-6.
25. Bhuiyan MS, Pattison JS, Osinska H, et al. Enhanced autophagy ameliorates cardiac proteinopathy. J Clin Invest. 2013; 123: 5284-97.
26. Choi JC, Worman HJ. Reactivation of autophagy ameliorates LMNA cardiomyopathy. Autophagy. 2013; 9: 110-1.
27. Nishida K, Kyoi S, Yamaguchi O, et al. The role of autophagy in the heart. Cell Death Differ. 2009; 16: 31-8.
28. Lavandero S, Troncoso R, Rothermel BA, et al. Cardiovascular autophagy: concepts, controversies and perspectives. Autophagy. 2013; 9: 1455-66.
29. Zhu H, Tannous P, Johnstone JL, et al. Cardiac autophagy is a maladaptive response to hemodynamic stress. J Clin Invest. 2007; 117: 1782-93.
30. Zhang D, Contu R, Latronico MV, et al. MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. J Clin Invest. 2010; 120: 2805-16.
31. Fidzianska A, Bilinska ZT, Walczak E, et al. Autophagy in transition from hypertrophic cardiomyopathy to heart failure. J Electron Microsc. 2010; 59: 181-3.
32. Godlewski J, Nowicki MO, Bronisz A, et al. MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol Cell. 2010; 37: 620-32.
33. Godlewski J, Bronisz A, Nowicki MO, et al. microRNA-451: a conditional switch controlling glioma cell proliferation and migration. Cell Cycle. 2010; 9: 2742-8.
34. Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell. 2003; 115: 577-90.
35. Gwinn DM, Shackelford DB, Egan DF, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell. 2008; 30: 214-26.
36. Egan D, Kim J, Shaw RJ, et al. The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR. Autophagy. 2011; 7: 643-4.
37. Egan DF, Shackelford DB, Mihaylova MM, et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science. 2011; 331: 456-61.
38. Papadakis M, Hadley G, Xilouri M, et al. Tsc1 (hamartin) confers neuroprotection against ischemia by inducing autophagy. Nat Med. 2013; 19: 351-7.
39. Castets P, Ruegg MA. MTORC1 determines autophagy through ULK1 regulation in skeletal muscle. Autophagy. 2013; 9: 1435-7.